Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-01-05 @ 3:08 PM
Study NCT ID:
NCT03343067
Status:
TERMINATED
Last Update Posted:
2019-11-27
First Post:
2017-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-13
First Submit QC Date:
None
Study First Post Date:
2017-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-10-22
Results First Submit QC Date:
None
Results First Post Date:
2019-11-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-08
Last Update Post Date:
2019-11-27
Last Update Post Date Type:
ACTUAL